Clinical Trials Logo

Abortion in Second Trimester clinical trials

View clinical trials related to Abortion in Second Trimester.

Filter by:
  • None
  • Page 1

NCT ID: NCT03346629 Not yet recruiting - Clinical trials for Abortion in Second Trimester

Outpatient Service for Mid-trimester Termination of Pregnancy

Start date: December 2017
Phase: Phase 4
Study type: Interventional

This study seeks to evaluate the safety, acceptability and feasibility of an outpatient "day procedure" for medical abortion at 13-18 weeks gestation. The study regimen will consist of a single dose of 200 mg mifepristone to be taken orally either at home or at the hospital, followed approximately 24 - 48 hours later with administration of 400 mcg misoprostol. Repeat doses of 400 mcg (two tablets) of misoprostol will be administered buccally every three hours until the abortion is achieved.

NCT ID: NCT02235155 Completed - Clinical trials for Abortion in Second Trimester

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

Start date: September 2014
Phase: N/A
Study type: Observational

The primary goal is to examine the efficacy and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Uzbekistan.

NCT ID: NCT01766388 Completed - Clinical trials for Abortion in Second Trimester

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia

Start date: December 2012
Phase: N/A
Study type: Observational

The primary goal of this study is to examine the efficacy and feasibility of a mifepristone combined with misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Armenia.